Conference presentations

Export 89 results:
[ Author(Desc)] Title Type Year
Filters: Type is Conference Proceedings  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
F
Foster GM, Ambrose JC, Hue S, Delpech V, Fearnhill E, Leigh Brown A, Geretti AM, UK HIV Drug Resistance Database.  2012.  Transmission dynamics of CRF50_A1D across most at risk communities in the UK. 19th International HIV Dynamics & Evolution Conference, 25-28 April 2012.
Fox J, Dudaz A, Green H, Dunn DT, Kaye S, McClure M, Fidler S, UK HIV Drug Resistance Database and UK Collaborative HIV Cohort Study.  2007.  Epidemiology of non-B clade forms of HIV-1 in MSM in the UK. 13th Annual Conference of the British HIV Association, 25-28 April 2007.
G
Geretti AM, Sabin CA, Dunn DT, UK HIV Drug Resistance Database and UK Collaborative HIV Cohort Study.  2006.  The H208Y mutation in reverse transcriptase is significantly associated with NRTI exposure, M184V and TAM mutation pathways. 15th International HIV Drug Resistance Workshop, 13-17 June 2006.
Geretti AM, Sabin CA, Dunn DT, Nebbia G, UK HIV Drug Resistance Database and UK Collaborative HIV Cohort Study.  2005.  Mutations at reverse transcriptase (RT) codons G196, Q207, H208, R211 and I214 are associated with drug experience and specific RT mutation patterns. 14th International HIV Drug Resistance Workshop, 7-11 June 2005.
Geretti AM, Phillips AN, Kaye S, Booth C, Garcia A, Mackie N, UK HIV Drug Resistance Database and UK Collaborative HIV Cohort Study.  2008.  Prevalence and patterns of antiretroviral drug resistance at low plasma HIV RNA load levels. 17th International HIV Drug Resistance Workshop, 10-14 June 2008.
Geretti AM, White E, Beloukas A, Orkin C, Tostevin A, Tilston P, Chadwick D, Leen C, Sabin CA, Dunn DT et al..  2016.  Impact of Transmitted Thymidine Analogue Mutations on Responses to First-Line ART. Conference on Retroviruses and Opportunistic Infections (CROI) 2016.
Geretti AM, Phillips AN, Kaye S, Booth C, Mackie N, UK HIV Drug Resistance Database and UK Collaborative HIV Cohort Study.  2009.  Detection of clinically relevant antiretroviral drug resistance mutations among treated patients undergoing testing at low levels of viraemia. 18th International HIV Drug Resistance Workshop, June 2009.
Geretti AM, Harrison LJ, Green H, Dunn DT, UK HIV Drug Resistance Database and UK Collaborative HIV Cohort Study.  2008.  Effect of HIV-1 subtype on virological and immunological response to first-line HAART. 6th European HIV Drug Resistance Workshop, 26-28 March 2008.
Geretti AM, White E, Beloukas A, Orkin C, Tostevin A, Tilston P, Chadwick D, Leen C, Sabin CA, Dunn DT et al..  2016.  Impact of Transmitted Thymidine Analogue Mutations on Responses to First-Line ART. International HIV Drug Resistance Workshop 2016.
Gifford RJM, Kellam P, Dunn DT, Pillay D, UK HIV Drug Resistance Database.  2006.  The impact of structural and functional constraints acting at the nucleic acid level on the evolution of drug resistance in HIV-1. 15th International HIV Drug Resistance Workshop, 13-17 June 2006.
Gifford RJM, de Oliveira T, Rambaut A, Pybus OG, Dunn DT, Vandamme A.M, Kellam P, Pillay D, UK HIV Drug Resistance Database.  2008.  Phylogenetic surveillance of viral genetic diversity and the evolving molecular epidemiology of human immunodeficiency virus type 1. 15th Conference on Retroviruses and Opportunistic Infections, February 2008.
Gifford RJM, Pillay D, UK HIV Drug Resistance Database.  2005.  Utilisation of HIV-1 subtype specific consensus sequences to explore treatment related mutational patterns within and between subtypes. 14th International HIV Drug Resistance Workshop, 7-11 June 2005.
Green H, Pozniak A, Porter K, UK HIV Drug Resistance Database.  2003.  Temporal patterns in the rate of transmitted resistance in the UK. 9th European AIDS Conference, 25-29 October 2003.
Green H, Tilston P, Fearnhill E, Dunn DT, UK HIV Drug Resistance Database.  2007.  The impact of different definitions on the estimated rate of transmitted HIV drug resistance in the UK. 2nd International Workshop on HIV Transmission, 26-28 August 2007.
Green H, Tilston P, Fearnhill E, Dunn DT, UK HIV Drug Resistance Database.  2007.  The impact of different definitions on the estimated rate of transmitted HIV drug resistance in the UK. 13th Annual Conference of the British HIV Association, 25-28 April 2007.
Grover D, Allen L, Edwards SG, Green H, Copas A, Forsyth S, Pillay D, UK HIV Drug Resistance Database and UK Collaborative HIV Cohort Study.  2005.  Predictors of death and response to therapy in patients with multi (three)-class drug resistant (MDR) HIV in the UK. 14th International HIV Drug Resistance Workshop, 7-11 June 2005.
Grover D, Allen L, Pillay D, Green H, Copas A, Forsyth S, Edwards SG, UK HIV Drug Resistance Database and UK Collaborative HIV Cohort Study.  2005.  Virological and clinical outcomes in patients with multi (three)-class drug resistance (MDR). 11th Annual Conference of the British HIV Association, 20-23 April 2005.
H
Harrison LJ, Geretti AM, Green H, Dunn DT, UK HIV Drug Resistance Database and UK Collaborative HIV Cohort Study.  2008.  Effect of HIV-1 subtype on virological and immunological response to first-line HAART. British HIV Association 14th Annual Conference, 23-25 April 2008.
Harrison LJ, Castro H, Cane P A, Pillay D, Booth C, Phillips AN, Geretti AM, Dunn DT, UK HIV Drug Resistance Database and UK Collaborative HIV Cohort Study.  2010.  The effect of transmitted HIV-1 drug resistance on pre-therapy viral load. International HIV & Hepatitis Virus Drug Resistance Workshop & Curative Strategies, June 2010.
Hodcroft E, Hadfield J, Fearnhill E, Phillips AN, Dunn DT, Pillay D, Leigh Brown A, UK HIV Drug Resistance Database.  2014.  HIV Virulence has not increased in the UK subtype B epidemic. Conference on Retroviruses and Opportunistic Infections (CROI), 3-6 March 2014.